CCRB Logo

Trial History Detail on 2007-09-04

CUHK_CCT00113

2006-08-31

Prospective

MSD

Prof. Albert Martin Li

Dr. Victor Abdullah

Tracy Tsen

26322861, 26360020, tracy-tsen@cuhk.edu.hk

Tel., fax, email

Prof. A.M Li

26322982, albertmli@cuhk.edu.hk

Tel., e-mail

Use of Leukotriene Receptor Antagonist in the Treatment of Allergic Rhinitis

Yes

2006-05-18

asthma, allergic rhinitis

Drug

Montelukast

26 weeks per subject

N/A

Include: Patient from 6-18 yrs old with asthma and allergic rhinitis Exclude: Subject with congenital nasal anomalies or had received systemically administered corticosteroids within 1 month of enrollment.

Randomized

Placebo

Double-blind

Parallel

2006-10-01

46

Complete

The primary outcome measures include nasal cytokine levels, nasal airflow and daily rhinitis scores.

Secondary outcomes measures include symptom-free days, blood eosinophil counts and spirometric parameters.

No

2009-11-26


Yes

Type Access Document Published On  
No documents yet.
  • Page 1 of 1.